These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7541587)

  • 1. Physiologic variations of serum testosterone within the normal range do not affect serum prostate-specific antigen.
    Monath JR; McCullough DL; Hart LJ; Jarow JP
    Urology; 1995 Jul; 46(1):58-61. PubMed ID: 7541587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation between serum prostate-specific antigen and prostate cancer is not influenced by the serum testosterone concentration.
    Monda JM; Myers RP; Bostwick DG; Oesterling JE
    Urology; 1995 Jul; 46(1):62-4. PubMed ID: 7541588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.
    Morgentaler A; Rhoden EL
    Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system.
    Vashi AR; Wojno KJ; Henricks W; England BA; Vessella RL; Lange PH; Wright GL; Schellhammer PF; Weigand RA; Olson RM; Dowell BL; Borden KK; Oesterling JE
    Urology; 1997 Jan; 49(1):19-27. PubMed ID: 9000179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal (circadian) and functional relationship between prostate-specific antigen and testosterone in healthy men.
    Mermall H; Sothern RB; Kanabrocki EL; Quadri SF; Bremner FW; Nemchausky BA; Scheving LE
    Urology; 1995 Jul; 46(1):45-53. PubMed ID: 7541585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.
    Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA
    Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rigorous bicycling does not increase serum levels of total and free prostate-specific antigen (PSA), the free/total PSA ratio, gonadotropin levels, or uroflowmetric parameters.
    Saka T; Sofikerim M; Demirtas A; Kulaksizoglu S; Caniklioglu M; Karacagil M
    Urology; 2009 Dec; 74(6):1325-30. PubMed ID: 19781750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen in men born with bladder exstrophy.
    Silver RI; Partin AW; Epstein JI; Chan DW; Carter HB; Jeffs RD; Gearhart JP
    Urology; 1997 Feb; 49(2):253-6. PubMed ID: 9037290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of ejaculation on serum levels of prostate specific antigen.
    Heidenreich A; Vorreuther R; Neubauer S; Westphal J; Engelmann UH; Moul JW
    J Urol; 1997 Jan; 157(1):209-11. PubMed ID: 8976253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of finasteride on prostate specific antigen: review of available data.
    Guess HA; Gormley GJ; Stoner E; Oesterling JE
    J Urol; 1996 Jan; 155(1):3-9. PubMed ID: 7490873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum prostate-specific antigen in healthy Chinese men: establishment of age-specific reference ranges.
    Lin WY; Gu CJ; Kao CH; Changlai SP; Wang SJ
    Neoplasma; 1996; 43(2):103-5. PubMed ID: 8843971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are total prostate-specific antigen serum levels in cirrhotic men different from those in normal men?
    Vicentini FC; Botelho LA; Hisano M; Ebaid GX; Lucon M; Lucon AM; Srougi M
    Urology; 2009 May; 73(5):1032-5. PubMed ID: 19286245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific reference levels of serum prostate-specific antigen and prostate volume in healthy Arab men.
    Kehinde EO; Mojiminiyi OA; Sheikh M; Al-Awadi KA; Daar AS; Al-Hunayan A; Anim JT; Al-Sumait AA
    BJU Int; 2005 Aug; 96(3):308-12. PubMed ID: 16042719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer.
    Ellis WJ; Etzioni R; Vessella RL; Hu C; Goodman GE
    J Urol; 2001 Jul; 166(1):93-8; discussion 98-9. PubMed ID: 11435831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in ARE-I region of prostate-specific antigen gene associated with low serum testosterone level and high-grade prostate cancer.
    Schatzl G; Marberger M; Remzi M; Grösser P; Unterlechner J; Haidinger G; Zidek T; Preyer M; Micksche M; Gsur A
    Urology; 2005 Jun; 65(6):1141-5. PubMed ID: 15893813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive criteria for prostate cancer detection in men with serum PSA concentration of 2.0 to 4.0 ng/mL.
    Kravchick S; Peled R; Dorfman D; Agulansky L; Ben-Dor D; Cytron S
    Urology; 2005 Sep; 66(3):542-6. PubMed ID: 16140074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.
    Chun FK; Perrotte P; Briganti A; Benayoun S; Lebeau T; Ramirez A; Lewinshtein DJ; Valiquette L; Guay JP; Karakiewicz PI
    BJU Int; 2006 Jul; 98(1):50-3. PubMed ID: 16831142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N; Smolkin ME; Bissonette E; Theodorescu D
    Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.